Found: 33
Select item for more details and to access through your institution.
Ribonucleotide reductase subunit M1 expression in resectable, muscle-invasive urothelial cancer correlates with survival in younger patients HARSHMAN ET AL. RRM1 EXPRESSION IN MUSCLE-INVASIVE UROTHELIAL CANCER.
- Published in:
- BJU International, 2010, v. 106, n. 11, p. 1805, doi. 10.1111/j.1464-410X.2010.09327.x
- By:
- Publication type:
- Article
Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 2, p. 125, doi. 10.1016/j.clgc.2020.10.006
- By:
- Publication type:
- Article
Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 186, doi. 10.1002/cam4.986
- By:
- Publication type:
- Article
Adjuvant Therapy Options in Renal Cell Carcinoma: Where Do We Stand?
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Phase II Study of Docetaxel and Oxaliplatin for Second-Line Treatment of Urothelial Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2009, v. 55, n. 5, p. 321, doi. 10.1159/000230695
- By:
- Publication type:
- Article
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2018, v. 78, n. 14, p. 1053, doi. 10.1002/pros.23662
- By:
- Publication type:
- Article
Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC).
- Published in:
- Prostate, 2018, v. 78, n. 12, p. 889, doi. 10.1002/pros.23645
- By:
- Publication type:
- Article
Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.
- Published in:
- Prostate, 2017, v. 77, n. 15, p. 1478, doi. 10.1002/pros.23424
- By:
- Publication type:
- Article
The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer.
- Published in:
- Prostate, 2017, v. 77, n. 13, p. 1303, doi. 10.1002/pros.23390
- By:
- Publication type:
- Article
Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival.
- Published in:
- Prostate, 2014, v. 74, n. 8, p. 820, doi. 10.1002/pros.22788
- By:
- Publication type:
- Article
Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00463
- By:
- Publication type:
- Article
Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell Carcinoma.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0153321
- By:
- Publication type:
- Article
Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 7, p. e2116536, doi. 10.1001/jamanetworkopen.2021.16536
- By:
- Publication type:
- Article
Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 4, p. 491, doi. 10.1080/0284186X.2017.1369565
- By:
- Publication type:
- Article
Non-Clear Cell Renal Cell Carcinoma, Part 2: Therapy.
- Published in:
- Clinical Advances in Hematology & Oncology, 2015, v. 13, n. 6, p. 383
- By:
- Publication type:
- Article
Non-Clear Cell Renal Cell Carcinoma, Part 1: Histology.
- Published in:
- Clinical Advances in Hematology & Oncology, 2015, v. 13, n. 5, p. 308
- By:
- Publication type:
- Article
The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients.
- Published in:
- Targeted Oncology, 2013, v. 8, n. 3, p. 203, doi. 10.1007/s11523-012-0252-7
- By:
- Publication type:
- Article
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of disease-free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial-level meta-analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Mind the gap: What is driving the survival disparity between the sexes in bladder cancer?
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 15, p. 2586, doi. 10.1002/cncr.29387
- By:
- Publication type:
- Article
Impact of baseline serum IL‐8 on metastatic hormone‐sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805).
- Published in:
- Prostate, 2020, v. 80, n. 16, p. 1429, doi. 10.1002/pros.24074
- By:
- Publication type:
- Article
Circulating and intratumoral immune determinants of response to atezolizumab plus bevacizumab in patients with variant histology or sarcomatoid renal cell carcinoma.
- Published in:
- Oncologist, 2023, v. 28, p. S15, doi. 10.1093/oncolo/oyad216.026
- By:
- Publication type:
- Article
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. 1026, doi. 10.1002/onco.13925
- By:
- Publication type:
- Article
The Impact of Cisplatin‐ or Non‐Cisplatin‐Containing Chemotherapy on Long‐Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 10, p. 1348, doi. 10.1634/theoncologist.2018-0739
- By:
- Publication type:
- Article
Anti‐PD‐1 Immunotherapy‐Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. 1013, doi. 10.1634/theoncologist.2018-0633
- By:
- Publication type:
- Article
Abiraterone Acetate: Targeting Persistent Androgen Dependence in Castration-Resistant Prostate Cancer.
- Published in:
- Advances in Therapy, 2013, v. 30, n. 8, p. 727, doi. 10.1007/s12325-013-0050-3
- By:
- Publication type:
- Article
The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2017, v. 23, n. 7, p. 755, doi. 10.1177/1076029616668405
- By:
- Publication type:
- Article
Harnessing the PD-1 Pathway in Renal Cell Carcinoma: Current Evidence and Future Directions.
- Published in:
- BioDrugs, 2014, v. 28, n. 6, p. 513, doi. 10.1007/s40259-014-0111-4
- By:
- Publication type:
- Article
Con.
- Published in:
- 2017
- By:
- Publication type:
- Proceeding